Home>Health>Newcastle robot surgery inquest: ‘Risk of further deaths’

Newcastle robot surgery inquest: ‘Risk of further deaths’

Image caption

Stephen Pettitt died after an operation to repair a valve in his heart

There “remains a risk of further deaths” from robotic heart surgery, a coroner has warned during an inquest into a man’s death.

Stephen Pettitt, 69, died after an operation led by Sukumaran Nair at the Freeman Hospital, Newcastle, in 2015.

He was the first patient in the UK to undergo the pioneering treatment.

Recording a narrative verdict, coroner Karen Dilks said his death came as a “direct consequence of the operation and its complications”.

“Mr Pettitt died due to complications of an operation to treat mitral valve disease and, in part, because the operation was undertaken with robotic assistance,” she said.

Ms Dilks said Newcastle Hospitals NHS Trust should establish a policy covering the use of expert doctors, known as proctors, brought in to provide advice during new procedures.

Two proctors left during Mr Pettitt’s operation and the inquest heard they could not have intervened in any case as they were not registered with the General Medical Council.

‘Catalogue of errors’

The coroner also said there was an “absence of any benchmark” for training on new intervention treatments.

In a statement after the inquest Mr Pettitt’s family said an “investigation revealed a catalogue of errors including significant deficiencies in training and competence of the surgeon who had performed the procedure, who was subsequently dismissed”.

“This was compounded by the fact that several observing clinicians left the theatre part way through the procedure, and were therefore unable to assist when difficulties arose,” they said.

Ms Dilks will send a series of recommendations to the trust outlining how its policies could be improved.

She will also contact the Royal College of Surgeons and the Department of Health to ask them to consider whether national guidelines should be brought in.

Source link

Review Overview


Leave a Reply

Your email address will not be published. Required fields are marked *